MBX Biosciences (MBX) Treasury Shares (2023 - 2026)
MBX Biosciences (MBX) reported Treasury Shares of $163562.0 for Q1 2026, up 1908.13% on a YoY basis from $8145.0 in Q1 2025, and up 23468.01% sequentially from $694.0 in Q4 2025.
MBX Biosciences (MBX) Treasury Shares (2023 - 2026) Analysis & Trends
MBX Biosciences (MBX) has 4 years of Treasury Shares data on file, last reported at $163562.0 in Q1 2026.
- For the quarter ending Q1 2026, Treasury Shares rose 1908.13% year-over-year to $163562.0; the trailing twelve-month figure through Mar 2026 stood at $163562.0 (up 1908.13% YoY), and the FY2025 full-year result was $694.0, down 94.5% from the prior year.
- Treasury Shares rose to $163562.0 in Q1 2026, from $694.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $129.2 million in Q3 2023 to a low of $694.0 in Q4 2025.
- A 4-year average of $47.0 million and a median of $18039.0 in 2024 frame the typical range for Treasury Shares.
- Across the five-year window, Treasury Shares slumped 100.0% in 2025 and jumped 1908.13% in 2026, its largest moves.
- Tracing MBX's Treasury Shares over 4 years: stood at $129.2 million in 2023, then sank by 99.99% to $12608.0 in 2024, then slumped by 94.5% to $694.0 in 2025, then jumped by 23468.01% to $163562.0 in 2026.
- Business Quant data shows MBX's Treasury Shares at $163562.0 in Q1 2026, $694.0 in Q4 2025, and $2514.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | MBX Biosciences | 2.96 Bn | 2.96 Bn | - | 163,562.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 163,562.00 |
| Mar 31, 2026 | 163,562.00 |
| Dec 31, 2025 | 694.00 |
| Dec 31, 2025 | 694.00 |
| Sep 30, 2025 | 2,514.00 |
| Sep 30, 2025 | 2,514.00 |
| Jun 30, 2025 | 5,077.00 |
| Jun 30, 2025 | 5,077.00 |
| Mar 31, 2025 | 8,145.00 |
| Mar 31, 2025 | 8,145.00 |
| Dec 31, 2024 | 12,608.00 |
| Dec 31, 2024 | 12,608.00 |
| Sep 30, 2024 | 18,039.00 |
| Sep 30, 2024 | 18,039.00 |
| Jun 30, 2024 | 129.24 Mn |
| Jun 30, 2024 | 129.24 Mn |
| Mar 31, 2024 | 129.24 Mn |
| Mar 31, 2024 | 129.24 Mn |
| Dec 31, 2023 | 129.24 Mn |
| Dec 31, 2023 | 129.24 Mn |